Contact

Autifony Therapeutics Limited

Registration No. 07543962, Registered in England
Stevenage Bioscience Catalyst,
Gunnels Wood Road,
Stevenage,
Hertfordshire,
SG1 2FX,
UK
VAT Registration No. 119 1039 38

Autifony Srl Company

Registration No. 387419, Registered in Italy,
Registered Office:

Contact us at: [email protected]

About

Autifony Therapeutics aims to develop new drugs to treat serious disorders of the central nervous system using pioneering science.

Science

Scientific publications can be found here as well as information on Voltage-gated ion channels as therapeutics targets and Kv3 ion channels.

Pipeline

Clinical stage programmes for schizophrenia and Fragile X, and earlier stage programmes focused on Hearing disorders and Alzheimer’s Disease.

Tweets

AutifonyLtd @AutifonyLtd
Autifony Therapeutic  @AutifonyLtd
Autifony Therapeutics achieves first milestone in agreement with Boehringer Ingelheim for a novel therapeutic appro… https://t.co/xOlDJ1kTe9 
Jan 18 reply retweet favorite 4 weeks ago
Autifony Therapeutic  @AutifonyLtd
Autifony is currently recruiting a Junior Medicinal Chemist, the position will be based in our lab in Stevenage, fo… https://t.co/PkP9TCxUcq 
Dec 04 reply retweet favorite 2 months ago
Autifony Therapeutic  @AutifonyLtd
RT @BIODeutschland:Boehringer Ingelheim & Autifony Therapeutics collaborate on a novel therapeutic approach to a range of CNS disorder… https://t.co/sIz3B7CkOe 
Dec 18 reply retweet favorite 1 year ago

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image